登革病毒診斷檢測市場規模、佔有率和成長分析：按檢測類型、檢測環境、檢體類型、最終用戶、技術、分銷管道和地區分類－2026-2033年產業預測

2024 年全球登革病毒診斷檢測市值為 7.34 億美元，預計到 2033 年將成長至 12.4008 億美元，而 2025 年為 7.7804 億美元，預測期（2026-2033 年）的複合年成長率為 6.0%。

全球登革病毒診斷檢測市場涵蓋試劑、試劑盒以及用於常規醫療機構的各種檢測平台。隨著登革熱疫情在包括東南亞和美洲在內的多個地區蔓延，對快速可靠的診斷解決方案的需求日益成長，以加強治療和控制。目前，檢測方法正從傳統的酵素連結免疫吸附試驗 (ELISA) 和聚合酶鍊式反應 (PCR) 方法顯著轉向即時檢測 (PoC)免疫疾病層析試紙和多分子檢測板。政府加大對登革熱監測的投入，推動了市場成長，促進了檢測套組的採購和實驗室網路的擴展。這些因素加速了研發進程，降低了成本，並有助於進入新興市場。此外，人工智慧和機器學習的進步正在革新快速診斷，實現近乎即時的檢測結果，提高檢測效率，最終增強醫療系統監測和集體爆發追蹤能力。

全球登革病毒診斷檢測市場按檢測類型、技術、檢體類型、最終用戶、分銷管道和地區進行細分。按檢測類型分類，市場分為分子檢測、血清學檢測、抗原檢測和快速診斷檢測 (RDT)。依技術分類，市場分為聚合酵素鏈鎖反應(PCR)、酵素免疫分析法(ELISA)、層析法法、核酸增幅檢查(NAAT) 和其他技術。依檢體類型分類，市場分為全血、血清、血漿和其他樣本。依最終用戶分類，市場分為醫院、診斷實驗室、學術和研究機構、血庫和其他機構。依分銷通路分類，市場分為直銷、分銷商/批發商、線上銷售及其他通路。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球登革病毒診斷檢測市場成長要素

都市區擴張無意中為埃及伊蚊的繁殖創造了有利環境，導致登革熱病例增加。這促使衛生組織將早期檢測列為優先事項。這種高度重視促使醫療機構推廣使用診斷試劑盒，從而顯著增加了對可靠檢測方案的需求。為此，製造商正在擴大生產規模、拓寬分銷管道並最佳化供應鏈，以確保在人口密集地區能夠方便地獲得診斷工具。隨著這些檢測方法被納入標準監測計劃，公共衛生緊急應變能力得到加強，從而鞏固了登革病毒診斷檢測市場持續成長的趨勢。

全球登革病毒診斷檢測市場面臨的限制因素

由於農村地區醫療資源有限，全球登革病毒診斷檢測市場面臨嚴峻挑戰。許多地區的醫療衛生系統設備不足，缺乏訓練有素的人員進行有效的登革熱診斷檢測。這種短缺阻礙了早期發現，導致治療延誤，並加重了本已醫療資源匱乏地區的疾病負擔。因此，儘管全球對高效診斷方法的需求不斷成長，但市場滲透率仍然很低，限制了其潛在成長。雖然推廣和能力建構工作可能有助於克服這些障礙，但實際操作中的限制和實施方面的挑戰仍將導致市場擴張進展緩慢。

全球登革病毒診斷檢測市場趨勢

全球登革病毒診斷檢測市場正呈現出快速即時診斷試劑盒迅速普及的顯著趨勢，這些試劑盒能夠提供即時檢測結果，從而支持快速的臨床決策。這一轉變與醫療服務分散化的大趨勢不謀而合，尤其是在新興市場的都市區診所和新醫院。製造商正透過簡化檢測流程、推出電池供電設備以及加強分銷網路來應對這一趨勢，從而提高基層醫療機構的可及性。這種對早期檢測日益重視的做法對於滿足公共衛生需求至關重要，最終將推動市場滲透，並進一步凸顯全球對抗登革熱的迫切性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球登革病毒診斷測試市場規模：按測試類型分類

• 分子檢測
  • RT-PCR檢測
  • 多重PCR檢測
• 抗原檢測
  • NS1抗原檢測
• 抗體檢測
  • IgM 檢測
  • IgG檢測
• 其他

全球登革病毒診斷檢測市場規模：依檢測環境分類

• 檢查室檢測
• 即時檢測

全球登革病毒診斷檢測市場規模：依樣本類型分類

• 全血
• 血清
• 電漿

全球登革病毒診斷檢測市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 公共衛生研究所
• 其他

全球登革病毒診斷檢測市場規模：依技術分類

• 基於PCR的檢測
• 基於ELISA方法的檢測
• 快速診斷測試
• 其他

全球登革病毒診斷檢測市場規模：按分銷管道分類

• 直接採購
• 醫療批發商
• 政府採購

全球登革病毒診斷檢測市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• QIAGEN NV
• Thermo Fisher Scientific Inc.
• bioMerieux SA
• Siemens Healthineers AG
• Sysmex Corporation
• SD Biosensor, Inc.
• CTK Biotech, Inc.
• InBios International, Inc.
• Euroimmun Medizinische Labordiagnostika AG
• Trivitron Healthcare Pvt. Ltd.
• CerTest Biotec SL
• Tulip Diagnostics Pvt. Ltd.
• J. Mitra & Co. Pvt. Ltd.
• ACON Laboratories, Inc.
• NovaTec Immundiagnostica GmbH
• MP Biomedicals, LLC

結論與建議

Global Dengue Virus Diagnostic Tests Market size was valued at USD 734.0 Million in 2024 and is poised to grow from USD 778.04 Million in 2025 to USD 1240.08 Million by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).

The global market for dengue virus diagnostic tests encompasses reagents, kits, and diverse detection platforms catering to everyday healthcare settings. The rising prevalence of dengue across various regions, including Southeast Asia and the Americas, demands rapid and reliable diagnostic solutions to enhance treatment and containment efforts. A shift from traditional ELISA and PCR methods toward point-of-care immunochromatographic strips and multiplex molecular panels is evident. Increased government investments in dengue surveillance are fostering growth, enabling test-kit procurement and laboratory network expansion, which enhances research and development, reduces costs, and opens access to emerging markets. Additionally, advancements in AI and machine learning are revolutionizing rapid diagnostics by facilitating near-instant interpretations and improving testing efficiency, ultimately bolstering health system surveillance and outbreak tracking.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dengue Virus Diagnostic Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dengue Virus Diagnostic Tests Market Segments Analysis

The global dengue virus diagnostic tests market is segmented by test type, technology, sample type, end user, distribution channel, and region. Based on test type, the market is segmented into Molecular Tests, Serological Tests, Antigen Detection Tests, and Rapid Diagnostic Tests (RDTs). Based on technology, the market is segmented into Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Immunochromatographic Assays, Nucleic Acid Amplification Tests (NAAT), and Others. Based on sample type, the market is segmented into Whole Blood, Serum, Plasma, and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Blood Banks, and Others. Based on distribution channel, the market is segmented into Direct Sales, Distributors & Wholesalers, Online Sales, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Dengue Virus Diagnostic Tests Market

The expansion of urban areas inadvertently creates favorable environments for Aedes mosquitoes, leading to an increase in dengue cases and prompting health agencies to prioritize early detection. This intensified focus drives healthcare providers to utilize diagnostic kits, resulting in a significant demand for reliable testing solutions. In turn, manufacturers respond by ramping up production, broadening distribution channels, and optimizing their supply chains to ensure that diagnostic tools are readily available in densely populated areas. As these tests become integrated into standard surveillance programs, public health preparedness is enhanced, thereby solidifying a sustained trajectory of growth within the dengue virus diagnostic tests market.

Restraints in the Global Dengue Virus Diagnostic Tests Market

The Global Dengue Virus Diagnostic Tests market faces significant challenges due to limited access in rural areas. Many local healthcare systems are inadequately equipped and lack sufficient trained personnel to conduct effective dengue diagnostic testing. This deficiency hampers early detection, leading to delays in treatment and an increased disease burden on already underserved communities. Consequently, the market penetration remains low, hindering potential growth despite the rising global demand for efficient diagnostics. While outreach and capacity-building initiatives may assist in overcoming these barriers, the practical constraints and rollout challenges contribute to the protracted timeline for market expansion.

Market Trends of the Global Dengue Virus Diagnostic Tests Market

The Global Dengue Virus Diagnostic Tests market is witnessing a significant trend towards the expansion of rapid point-of-care diagnostic kits, which provide immediate results and facilitate swift clinical decision-making. This shift aligns with the broader movement toward decentralized healthcare services, particularly in urban clinics and newer hospitals within emerging markets. Manufacturers are adapting by streamlining assay workflows, integrating battery-operated devices, and enhancing distribution networks, thereby increasing accessibility to primary care settings. This growing emphasis on timely detection is essential for addressing public health needs, ultimately driving market penetration and reinforcing the urgency of effective dengue management globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Dengue Virus Diagnostic Tests Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Molecular Tests
  • RT-PCR Tests
  • Multiplex PCR Tests
• Antigen Detection Tests
  • NS1 Antigen Tests
• Antibody Detection Tests
  • IgM Tests
  • IgG Tests
• Others

Global Dengue Virus Diagnostic Tests Market Size by Testing Setting & CAGR (2026-2033)

• Market Overview
• Laboratory-Based Testing
• Point-of-Care Testing

Global Dengue Virus Diagnostic Tests Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Whole Blood
• Serum
• Plasma

Global Dengue Virus Diagnostic Tests Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Public Health Laboratories
• Others

Global Dengue Virus Diagnostic Tests Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR-Based Testing
• ELISA-Based Testing
• Rapid Diagnostic Testing
• Others

Global Dengue Virus Diagnostic Tests Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Procurement
• Medical Distributors
• Government Procurement

Global Dengue Virus Diagnostic Tests Market Size & CAGR (2026-2033)

• North America (Test Type, Testing Setting, Sample Type, End User, Technology, Distribution Channel)
  • US
  • Canada
• Europe (Test Type, Testing Setting, Sample Type, End User, Technology, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Testing Setting, Sample Type, End User, Technology, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Testing Setting, Sample Type, End User, Technology, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Testing Setting, Sample Type, End User, Technology, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTK Biotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InBios International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Euroimmun Medizinische Labordiagnostika AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CerTest Biotec S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Mitra & Co. Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovaTec Immundiagnostica GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MP Biomedicals, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations